ClinicalTrials.govpublic full text
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
esophageal carcinoma, radiotherapy, immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 623519
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.